BioScrip
Option Care Health (formed from the BioScrip/Option Care merger) is a US national provider of home and alternate site infusion therapy, delivering IV antibiotics, immunoglobulin, nutrition support, oncology, and specialty therapies through infusion suites, clinics, and home-based nursing for patients, prescribers, and healthcare partners.
- Company typePublic
- Founded1990
- HeadquartersDoral, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What BioScrip does
Option Care Health, formed from the August 2023 merger of BioScrip and Option Care, is a US-based, publicly traded national provider of home and alternate site infusion therapy services operating from its headquarters in Doral, Florida with 1,001-5,000 employees. The company delivers a broad therapeutic portfolio spanning IV antibiotics, nutrition support (Restore+ program), immunoglobulin infusion (IG Complete+), chronic inflammatory disorder treatment, neurological disorder treatment, oncology therapies, bleeding disorder treatment, women's health/obstetrics, heart failure care, and specialized therapies. Services are delivered through three channels — company-operated infusion suites, infusion clinics, and home-based infusion with qualified nursing staff — giving patients and prescribers flexibility across care settings.
The underlying operating model is a healthcare service delivery platform rather than a technology product: clinical operations are supported by an internal technology function (CSI Network Services), and the company maintains stacked accreditations including URAC Specialty Pharmacy (through March 2029), ACHC, ASHP, PCAB compounding pharmacy, and AICPA SOC 1/2/3 compliance. Pricing is not publicly disclosed; reimbursement is handled through insurance providers, Medicare, and Medicaid, with patient financial counseling and Good Faith Estimates offered for uninsured or self-pay patients. The go-to-market motion is enterprise field sales executed through healthcare provider referrals, direct patient acquisition, and a four-pillar partner ecosystem covering pharmaceutical manufacturers, insurance providers, health systems, and nursing providers. Customer segmentation is horizontal, addressing multiple therapeutic use cases through a single integrated clinical delivery network rather than vertical specialization.
BioScrip firmographics
Firmographics- Name
- BioScrip
- Legal name
- Option Care Health Inc.
- Website
- https://bioscrip.com
- Company type
- Public
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Option Care Health (formed from the BioScrip/Option Care merger) is a US national provider of home and alternate site infusion therapy, delivering IV antibiotics, immunoglobulin, nutrition support, oncology, and specialty therapies through infusion suites, clinics, and home-based nursing for patients, prescribers, and healthcare partners.
- Ownership category
- akta.pro rank
Where BioScrip is headquartered
LocationHeadquarters
- HQ city
- Doral
- HQ country
- United States
- HQ region
- North America
Markets served
BioScrip business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Infusion Therapy Services: Revenue generated through reimbursement for providing infusion therapy treatments to patients. Services are billed to insurance providers and Medicare/Medicaid. The company provides various therapeutic infusion services including antibiotics, immunoglobulin, nutrition support, and specialty therapies.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
BioScrip product offering
Product offeringCore offering
BioScrip (now part of Option Care Health following the August 2023 merger) provides home and alternate site infusion therapy services delivered through infusion suites, infusion clinics, and home-based nursing care. Therapeutic offerings span IV antibiotics, nutrition support, immunoglobulin, chronic inflammatory disorders, neurological disorders, oncology therapies, bleeding disorders, women's health, heart failure care, and specialized therapies. Services are billed to insurance providers, Medicare, and Medicaid.
Product overview
BioScrip, now part of Option Care Health following the August 2023 merger, operates as a comprehensive infusion care provider offering a unified portfolio of therapeutic services and patient support programs. The core offering consists of Therapeutic Services across multiple specialties (IV antibiotics, nutrition support, immunoglobulin, chronic inflammatory disorders, neurological disorders, oncology, bleeding disorders, women's health, heart failure, and specialized therapies), delivered through Infusion Suites and Infusion Clinics. Specialized programs include IG Complete+ for immunoglobulin therapy and Restore+ Nutrition Support for nutritional therapy. The company supports patients through education resources, insurance guidance, and financial counseling, while providing healthcare providers with prescriber order forms. Business partnerships with pharmaceutical manufacturers, health systems, insurance providers, and nursing providers extend service delivery capabilities. An internal CSI Network Services division supports technology infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- Therapeutic Infusion Services Comprehensive infusion therapy services including IV antibiotics, immunoglobulin infusion, chronic inflammatory disorder treatment, neurological disorder treatment, oncology therapies, bleeding disorder treatment, women's health/obstetrics, heart failure care, and specialized therapies, delivered to patients in home, infusion suite, or clinic settings.
- IG Complete+ Specialized immunoglobulin therapy program providing care for patients requiring immune globulin treatments, supporting providers and patients through a dedicated program pathway.
- Restore+ Nutrition Support Comprehensive nutrition support program for patients requiring specialized parenteral or enteral nutritional therapy delivered via infusion in home or clinical settings.
- Infusion Suites Dedicated clinical spaces where patients receive infusion therapies in a comfortable, supervised medical environment as part of the company's national network.
- Infusion Clinics Outpatient clinical facilities offering infusion therapy services for patients requiring regular treatments, with locations across the United States.
- Home Infusion Services Home-based infusion therapy services delivered by qualified nursing staff to patient residences, enabling care outside of hospital or clinical settings.
Companies that use BioScrip
Customer profileSegments3 records
Ideal customer profiles3 records
BioScrip technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioScrip partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and supporting.
- Pharmaceutical ManufacturerscoreOption Care Health partners with pharmaceutical manufacturers to provide seamless clinical and administrative support for infusion therapies. The partnership enables coordination for specialty drug administration and patient support programs.
- Insurance ProviderscorePartnerships with insurance providers to coordinate coverage for infusion therapy services. The company assists patients with insurance coverage and costs, working with payers to ensure access to care.
- Healthcare SystemscorePartnerships with healthcare systems to provide seamless clinical and administrative support. Enables coordination of patient care across hospital and alternate site settings.
- Nursing ProviderssupportingPartnerships with nursing providers to deliver home infusion services. Coordinates skilled nursing care for patients receiving infusion therapy at home.
Scale indicators1 record
Recent moves7 records
Expansion highlights4 records
BioScrip competitors and assessment
Company assessmentBroad incumbents
- McKesson Specialty Health: McKesson Specialty Health distributes specialty pharmaceuticals and operates provider services supporting oncology and infusion practices, giving it broad reach into the same therapeutic categories as Option Care Health though via a distributor-led model.
- Accredo Specialty Pharmacy: Accredo, owned by Express Scripts/Cigna, is one of the largest U.S. specialty pharmacies with significant home infusion capabilities; it overlaps with Option Care Health in specialty drug delivery but operates as part of a vertically integrated payer/PBM model.
- Optum Infusion Pharmacy: Optum, the UnitedHealth Group health services arm, operates infusion pharmacy services alongside its broader payer, PBM, and care delivery portfolio, competing with Option Care Health particularly through OptumRx and UnitedHealthcare network access.
- Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy provides specialty drug fulfillment and some home infusion services as part of its broad retail and healthcare footprint, overlapping with Option Care Health in chronic and specialty therapy delivery.
Direct peers
- PromptCare: PromptCare provides home and alternate-site infusion nursing and specialty pharmacy services across multiple U.S. regions, competing head-to-head with Option Care Health for prescribers, patients, and payer contracts in the home infusion segment.
- Soleo Health: Soleo Health is a national specialty infusion provider offering home and alternate-site infusion therapies for immunology, neurology, oncology, infectious disease, and rare conditions, with specialty pharmacy capabilities similar to Option Care Health.
- Amerita: Amerita is a specialty home infusion provider serving patients with complex conditions including IV antibiotics, nutrition support, immunoglobulin, and chronic disease therapies; comparable to Option Care Health in therapeutic scope and home-based delivery model.
- Coram CVS Specialty Infusion Services: Coram, owned by CVS Health, is one of the largest U.S. home infusion therapy providers, offering IV antibiotics, total parenteral nutrition, immunoglobulin, and specialty drug infusion across all 50 states — directly comparable to Option Care Health's national home and alternate site infusion network.
- BioPlus Specialty Pharmacy: BioPlus, owned by Elevance Health, is a specialty pharmacy and home infusion provider focused on complex conditions including oncology, immunology, and rare diseases, directly comparable to Option Care Health's specialty therapy programs.
Others
- CareCentrix (formerly Humana/Signify Health): CareCentrix manages post-acute and home-based care for payers and providers; it does not directly deliver infusion therapy but is an ecosystem participant that can shape referrals and network decisions relevant to home infusion providers like Option Care Health.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BioScrip social profiles
Digital presenceBioScrip compliance and trust
Trust signalCompliance6 records
BioScrip financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioScrip leadership team
Management profileNumber of profiles
BioScrip subsidiaries and ownership
Company hierarchySubsidiaries1 record
BioScrip funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioScrip M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioScrip
What does BioScrip do?
BioScrip (now part of Option Care Health following the August 2023 merger) provides home and alternate site infusion therapy services delivered through infusion suites, infusion clinics, and home-based nursing care. Therapeutic offerings span IV antibiotics, nutrition support, immunoglobulin, chronic inflammatory disorders, neurological disorders, oncology therapies, bleeding disorders, women's health, heart failure care, and specialized therapies. Services are billed to insurance providers, Medicare, and Medicaid.
Is BioScrip a public or private company?
BioScrip is a public company. It is classified as public and is currently operating.
When was BioScrip founded?
BioScrip was founded in 1990. It employs 1,001 to 5,000 people.
Where is BioScrip based?
BioScrip is headquartered in Doral, United States, in the North America region.
How does BioScrip make money?
One revenue line is on record: infusion Therapy Services.
Who are BioScrip's main competitors?
Broad incumbents on record are McKesson Specialty Health, Accredo Specialty Pharmacy, Optum Infusion Pharmacy and Walgreens Specialty Pharmacy. Direct peers are PromptCare, Soleo Health, Amerita, Coram CVS Specialty Infusion Services and BioPlus Specialty Pharmacy. CareCentrix (formerly Humana/Signify Health) is listed as an others.
Does BioScrip have an API?
No public API is recorded for BioScrip.